Peng Huang, M.D., Ph.D. University of Texas MD Anderson Cancer Center

Dr. Peng Huang obtained his medical training at Sun Yet-sen University Medical School (formerly Zhongshan Medical College), and his Ph.D. from the University of Texas, Graduate School of Biomedical Sciences, in Houston in 1990. He completed his postdoctoral training in Department of Experimental Therapeutics, MD Anderson Cancer Center, and is currently a Professor at the Department of Molecular Pathology, the University of Texas MD Anderson Cancer Center.

Dr. Huang's research interest is in the areas of cancer biology, mechanisms of action of anticancer agents, and drug development. Currently, his laboratory research focuses on the mechanisms underlying the alterations in energy metabolism and redox imbalance in cancer cells, with an emphasis on mitochondrial dysfunction, reactive oxygen species (ROS) stress, and strategies to target these abnormalities in cancer cells for therapeutic purpose. The long-term goal of his research is to translate the new knowledge gained from laboratory research into clinical therapeutic strategies for effective treatment of cancer. Dr. Huang's research program is based on two long-standing observations: the Warburg effect (increased aerobic glycolysis in cancer) and elevated ROS generation in cancer cells. Dr. Huang's research program is supported by grants from the National Institutes of Health, CLL Global Research Foundation, and other funding agencies.